SUMMARY Cancer morbidity at all sites has been studied in a series of 676 patients with ulcerative colitis under long-term review, of whom more than two-thirds had extensive disease, and the level and pattern of risk over time examined. Age-, sex-, and site-specific incidence rates were used to compute the number of cancers that might have been expected to occur. A highly significant excess of cancers was observed overall but the excess was due entirely to cancers of the digestive system. In women there was no excess or deficit of cancers outside the digestive system. In men there was a small deficit of cancers of the respiratory system. An overall 11-fold excess colorectal cancer risk was found in the series compared with that in a relevant general population after patient-years at risk had been corrected for surgical resection and patients with colorectal cancer at their first referral had been excluded. When these data were expressed in an actuarial form the cumulative probability of developing colorectal cancer in the series was 8% (3.5-13%) at 25 years, after the diagnosis of ulcerative colitis had been established. The relative risk of developing colorectal cancer was highest in those patients developing colitis before the age of 30 years, and the relative risk fell as the age at diagnosis of their colitis increased. The pattern of risk of colorectal cancer over time suggests that there is an association between cancer and colitis in susceptible individuals and that the level of risk is related to age at onset of colitis.
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Previous studies of the cancer risk in ulcerative colitis 1-8 have been confined almost exclusively to colorectal cancer, with the exception of the hepatobiliary system, which has received some attention.10 There is little information about the cancer incidence at other sites. We have therefore studied the whole spectrum of cancer morbidity in a series of patients with ulcerative colitis. This enabled us to examine some aspects of patient selection (analysis of clinical series being subject to many elements of bias3) to provide a basis from which to approach the specific problem of colorectal cancer.
Estimates of the incidence of colorectal cancer complicating ulcerative colitis in the early literature were based on crude percentages. 1 [4] [5] [6] [7] have compared the risk in the series with that in a relevant general population. Despite these reports, the magnitude and the pattern of risk is uncertain and varies from one reported series to another. These variations probably reflect differences in the composition of the reported series and in the methods used to evaluate the risk rather than real differences in the underlying cancer risk. The differing approaches to analysis have been discussed both in general3 611 and in individual series.7
We have attempted to identify and, where possible, to correct for areas of bias that can arise in analysing data from a clinical series. The increasing incidence of cancer that might be expected to occur in any series under long-term review -that is, an ageing population -has been taken into account when assessing the risk which might otherwise be attributed to the presence of ulcerative colitis. Nearly half the patients were seen in their first attack. The remainder were referred later in the course of their disease. As these 'referred' cases were included, the bias at entry to the series was inclined towards severe disease, particularly as patients were often referred for surgical treatment. This accounts for the high proportion of patients treated by panproctocolectomy (Table 1) compared with other reported series. It was difficult to define The age-distribution at onset and diagnosis is shown in Fig. 1 . The extent of the disease and the frequency of surgical resection is shown in Table 2 . Extensive colitis was defined as involvement of the large intestine as far proximally as the hepatic flexure.
The diagnosis of colorectal cancer was confirmed in all cases by a review of the histopathological material, and an accurate Dukes's classification was made whenever possible. order to correct for excision of the large intestine or rectum, the patient-years at risk accruing after colectomy or panproctocolectomy were subtracted from the total patient years at risk to give 'colorectal-years' at risk.
Expected numbers of cancers Incidence rates for cancer at individual anatomical sites were computed from data held at the Birmingham and West Midlands Regional Cancer Registry for the years 1960-62, the mid-point of the study. The age-, sex-, and site-specific incidence rates were applied to the corresponding patient-years at risk to compute the number of cancers that might be expected to occur in the series during the period of review. The expected numbers of colorectal cancers were computed both for total and for 'colorectal years' at risk. Colorectal cancers observed in the series were divided by mode of diagnosis into three clinical groups. These groups reflect possible areas of bias in the selection of patients which could affect the estimates of cancer risk. 1 'Referred' Symptoms of cancer in this group were instrumental in initiating the first referral of the patient to the unit, and, therefore, represent selection for cancer. 2 'Non-symptomatic' The cancers included in this group were identified as incidental findings among patients undergoing panproctocolectomy for symptomatic colitis shortly after referral to the unit, having been diagnosed elsewhere. The presence of the cancer was not considered to have initiated referral. 3 'Interval' These cancers were identified at review or at operation at least one year after the date first seen at the Unit. Cancers were allocated to these groups on review of the clinical material before the tabulations of expected numbers were drawn up and none was changed subsequently.
The pattern of cumulative relative risk (sum of the observed/sum of the expected numbers) of colorectal cancer over time was first determined by using all observed cancers with expected numbers uncorrected for operation. The analysis was repeated with the expected numbers corrected for operation. Three further analyses were carried out to show the effect that eaoh of the three clinical groups of observed cancers had on the level of risk and the pattern of risk over time, using as observed numbers:
A 'Referred' + 'non-symptomatic' + 'interval' cancers B 'Non-symptomatic' + 'interval' cancers C 'Interval' cancers only. In each case the expected numbers were corrected for operation.
A conventional actuarial analysis was performed using 'non-symptomatic' + 'interval' cancers with 'colorectal' years at risk.
The level and pattern risk of colorectal cancer over time was also examined in relation to age at diagnosis of ulcerative colitis for three age-ranges (0-29 years, 30-44 years, and 45+ years) using (non-symptomatic' and 'interval' cancers with the expected numbers corrected for operation. The results are presented by the main anatomical divisions, with expected numbers for colon and rectum corrected for resection.
Results
A highly significant excess of cancers overall was observed in the series (Table 3 ). The excess was due entirely to cancers diagnosed within the digestive system, for which the relative risk was of the same order for both men and women. In women, no other system or site was significantly over-or underrepresented in the observed numbers. In men, the excess overall was significant at only the 5% level because of a small deficit (of marginal statistical significance) of cancers of the respiratory system.
A more detailed analysis of cancers of the digestive system is shown in Table 4 . The excess of cancers in the colon and rectum was highly significant both for men and women, and the level of risk for the colon was the same as that for the rectum. A highly significant excess of cancers was found in liver and gall bladder. The remainder of the tract showed a small deficit which was of marginal significance and was due mainly to the absence of stomach cancers in this series. However, when those sites which showed a significant excess of cancers had been accounted for -namely, colon, rectum, liver and gall bladder -the expected number for all other sites (29.36) was close to the number observed (27).
Thirty-five colorectal cancers were observed in the series during the review period comprising 12 referred cancers, 10 non-symptomatic, and 13 interval cancers. The clinical details of the cancers including site, Dukes's classification, and outcome are summarised in Table 5 .
When no correction was made to the expected numbers, the risk of colorectal cancer relative to the general population decreased with time from the diagnosis of ulcerative colitis from 15*5-fold at five years to 9.3-fold at the end of the review period (Fig. 2, A' ). Correction for operation resulted in a 17-fold constant cumulative relative risk in the review period from five years after the diagnosis of ulcerative colitis had been established ( Fig. 2A) . The effects of the previously defined cancer groups on the estimates of cancer risk are illustrated in Fig. 3 . The constant 17-fold risk, which was obtained when all cancers (referred, non-symptomatic, and interval) were included (Fig. 3A) , was reduced to an 11-fold risk when 'referred' cancers were excluded from the analysis (Fig. 3B) . The relative risk still remained constant over time. When the 'interval' cancers alone were considered, the pattern of risk changed. There was an increasing relative risk of developing cancer up to 15 years from the diagnosis of ulcerative colitis with a constant six-fold risk thereafter (Fig. 3C) . These results emphasise the disparity between estimates of risk that can arise as a result of arbitrary selection of data.
It is generally, although not invariably,'6 accepted that 'referred' cancers should be excluded from the analyses, as they are selectively drawn by their symptoms of cancer from an unknown group of patients with ulcerative colitis in the general population. In the remaining analyses, therefore, these referred cancers were excluded and 'nonsymptomatic' and 'interval' cancers only were considered.
The actuarial analysis showed that the probability of developing colorectal cancers in the series increased exponentially with time (Fig. 4) . Despite the size of the initial series the 95% confidence limits for the estimation became increasingly wide with time. The probability at 25 years was 8% (3.5-13%) and 20% (4.5-36%) at 30 years but the figure at 30 years is based on the addition of only one further cancer. As the expected cancer risk increased at a similar rate the cumulative relative risk (O/E) over time remained constant and at the same level as shown in Fig. 3B .
The relative risk of developing colorectal cancer was 38-fold overall in patients aged between 0-29 years when their ulcerative colitis was diagnosed and it fell as the age at diagnosis increased ( ................................................B   -------------------------- 5 ). There was a two-fold risk among patients diagnosed with ulcerative colitis after 45 years of age ( Fig. 5 ) but this did not reach statistical significance (Table 6 ).
The cancers in the series were diagnosed at a relatively early age when compared with those expected in the general population (Fig. 6) . The age-specific relative risk decreased with age even though a substantial number of person-years at risk (1430.7 at 60+ years) was available for analysis. The risk of cancer in the colon and rectum when analysed separately was similar with an 11-fold risk (Table 7) .
Discussion
A highly significant excess of cancers of the digestive system was found in the series, the increased risk being confined to cancers of the colon, rectum, and gall bladder. The fact that the numbers of cancers observed at other sites were close to the numbers expected suggests that there was no undue selection for cancers of the digestive tract in preference to other sites. The increased colorectal cancer risk in the series when compared with that in the general population is likely therefore to be real rather than due to selection factors operating in the series. .,. Aviv (Table 8) . A more conservative estimate of the risk in this series can be calculated by considering only those cancers diagnosed after one or more years of follow-up ('interval' cancers). This eliminates any possible bias in the series arising from early cancers identified unexpectedly ('nonsymptomatic' cancers) in patients referred to the unit specifically for early surgical treatment. When 'interval' cancers alone are considered there is a six-fold overall risk in the series. The pattern of increased colorectal cancer risk over time in this series is of interest, as, whichever model is used, there is a constant increased risk with time 15 years after diagnosis rather than a rising risk with time as might have been expected (Fig. 3) . This applies to all ages of onset of disease (Fig. 5) . This constant risk is surprising, as a rising relative risk with time might be expected if inflammation were acting as an additional promotional factor for the development of cancer in the ulcerative colitis group when compared with the general population.
The cancer risk in the colon and rectum is similar if the two sites are analysed separately ( Table 7) . As the rectum is almost invariably involved from onset of disease a higher relative risk of rectal cancers might be expected if inflammation were implicated as a promotional factor. The constant relative risk over time and the marked effect of age at onset on the level of the colorectal cancer risk may be clues to the aetiology of colorectal cancer in ulcerative colitis but the relationship is as yet unexplained.
